Added to YB: 2024-11-28
Pitch date: 2024-10-21
LNTH [bullish]
Lantheus Holdings, Inc.
-40.56%
current return
Author Info
No bio for this author
Company Info
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.
Market Cap
$3.5B
Pitch Price
$112.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
8.83
P/E
22.15
EV/Sales
2.46
Sector
Health Care Equipment and Supplies
Category
growth
Carillon Eagle Small Cap Growth Fund Portfolio Holding: Lantheus Holdings, Inc.
LNTH: Imaging diagnostics & AI co beats rev. CMS proposes separate outpatient reimbursement for PYLARIFY (prostate cancer imaging agent), avoiding revenue pressure as pass-through status expires. Strong Q & promising radiopharmaceutical pipeline support future growth.
Read full article (1 min)